ArticlePloS one2024
The intra-day and inter-day reliability of a 6-second Wingate to determine maximal peak power in endurance-trained athletes.
Article in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Determining an athlete's maximal peak power (MPP) is crucial in profiling endurance sports participants. While short (3 to 6 seconds) all-out efforts have been validated for MPP assessment, prior studies mainly involved non-endurance trained athletes. This study aimed to assess the intra- and inter-day reliability of a 6-second Wingate test for MPP determination in endurance athletes. Endurance-trained participants (22 males, 5 females) completed nine 6-second Wingate tests over four days (3 trials at baseline, 2 trials on each subsequent day). Analysis revealed no systematic differences in MPP (F(4.09, 106.3) = 1.88, p = 0.117) or time to peak power (χ2 (8) = 5.23, p = 0.732) across the trials. Reliability, assessed through the intraclass correlation coefficient (ICC) and standard error of measurement (SEM), was excellent across all trials (ICC = 0.95, SEM = 40.0W, SEM% = 3.7%). Absolute reliability improved when selecting the average or the best MPP values from each day (SEM% = 2.7% and 2.9%, respectively). Within-day reliability was consistently rated as excellent, with the best values on the 4th day of tests. No significant differences in MPP values occurred between the first and second 6-second Wingate tests on days 1 to 3, with both trials demonstrating similar reliability values (SEM%: 3.2% vs 2.8%, for the first and second trials, respectively). The test also demonstrated a good sensitivity to detect a meaningful change in MPP values. In conclusion, the 6-second Wingate test proves reliable for determining MPP in endurance-trained athletes. Two trials are recommended on the first day of testing, with a single MPP likely sufficient to determine the athlete's MPP on subsequent days.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.